A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm

NCT00942851 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Focal Dystonia

Interventions

DRUG: Acetyl-Hexapeptide Topical Treatment
DRUG: placebo

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborators

[object Object]